COVID-19 Oral Medicine Market Trends, Analysis and Forecast till 2028 | Key Players Novartis AG, Merck & Co, Atea Pharmaceuticals, Ridgeback Biotherapeutics, Pfizer Inc

Market Study Report recently added a new title on 2022-2028 Global COVID-19 Oral Medicine Market Report from its database. The report provides study with in-depth overview, describing about the Product, Size, Share, Industry Scope and elaborates market outlook and status to 2028.

According to certified experts, global COVID-19 oral medicine market is estimated to expand at a CAGR of around 10.5% CAGR during the forecast period of 2022-2028.

One of the primary reasons fueling the growth of global COVID-19 oral medicine market is the rising investment by prominent players.

Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/5587036/

The COVID-19 pandemic has devastated the world and impacted millions of people. The demand for the creation of therapeutic treatments has increased due to the pandemic outbreak. Moreover, a variety of medications, including monoclonal antibodies, antivirals, and kinase inhibitors, can be used to treat COVID-19.

Aside from that, strategic alliances between major corporations and increased R&D endeavors are assisting in the growth of the corporate environment.

Worldwide COVID-19 oral medicine market is classified based on drug class, end-user terrain, and distribution channel.

Based on the drug class, the marketplace is categorized into Immune modulators, monoclonal antibodies, antiviral, anticoagulant, and others (sedatives, etc.). Among these, the antiviral segment is expected to hold the largest market share in the ensuing years.

Moving on to the distribution channels, the industry is bifurcated into online and offline. With respect to the end-user terrain, the market is fragmented into clinics, home settings, hospitals, and others (academic & research institutes).

The geographical analysis of this industry extends to Latin America (Brazil and Mexico), the Middle East & Africa (South Africa, Turkey, and GCC,), Asia-Pacific (India, Australia, South Korea, China, Japan, ASEAN {Indonesia, Malaysia, Vietnam, etc.}), North America (US, Canada), and Europe (France, Spain, UK, Italy, Germany, Nordic, Benelux, Poland, Russia).

The competitive landscape of the global COVID-19 oral medicine industry is defined by companies such as Regeneron Pharmaceuticals Inc., Novartis AG, Dr. Molecular Partners AG, Reddy's Laboratories, Glenmark Pharmaceuticals Limited, Emcure Pharmaceuticals Limited, F. Hoffmann-La Roche AG, Atea Pharmaceuticals, Strides Pharma Science Limited, Ridgeback Biotherapeutics, and Pfizer Inc.

Question & Answer: Global COVID-19 Oral Medicine Market

Question 1: Which factors are contributing to global COVID-19 oral medicine market growth?

Answer: The rising investment by prominent players is one of the primary factors driving the expansion of global COVID-19 oral medicine market.

Question 2: How has COVID-19 influenced global COVID-19 oral medicine market?

Answer: The demand for the creation of therapeutic treatments has increased due to the pandemic outbreak. Moreover, a variety of medications, including antivirals, monoclonal antibodies, and kinase inhibitors, can be used to treat COVID-19.

Question 3: Which companies are profiled in the global COVID-19 oral medicine market report?

Answer: The competitive landscape of the global COVID-19 oral medicine market is defined by companies such as Regeneron Pharmaceuticals Inc., Molecular Partners AG, Novartis AG, Dr. Reddy's Laboratories, Glenmark Pharmaceuticals Limited, Emcure Pharmaceuticals Limited, F. Hoffmann-La Roche AG, Atea Pharmaceuticals, Strides Pharma Science Limited, Ridgeback Biotherapeutics, Merck & Co. Inc., and Pfizer Inc.

For More Details on This Report @ https://www.marketstudyreport.com/reports/covid-19-oral-medicine-market-investment-growth-opportunity-analysis-2019-2028

Contact Us:

Ritesh Tiwari
Head - Press and Media
Email: sales@marketstudyreport.com
Phone: 1-866-764-2150
MarketStudyReport.com

About US:

Market Study Report is a hub for market intelligence products and services.

We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.

Our customers partner with Market Study Report, to ease their search and evaluation of market intelligence products and services and in turn focus on their company's core activities.

If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, is the platform that can help you in achieving any of these objectives.

This release was published on openPR.